Artificial Circulatory Pump Membrane for Hemolysis-Safe Pulsatile Flow

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current cardiopulmonary bypass systems using linear flow pumps cause blood trauma, hemolysis, and complications due to the absence of pulsatile flow, leading to inadequate blood pressure regulation and increased risk of cardiovascular morbidity and mortality in patients with refractory arterial hypertension.

Innovation Solution

Development of a membrane for artificial circulatory assistance chambers that provides pulsatile flow by varying internal volume without distension or contraction, made from impermeable, flexible non-elastic material to prevent stagnation points and ensure continuous blood flow, simulating physiological cardiac flow and reducing peripheral resistance.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If linear flow pumps are used in cardiopulmonary bypass systems, then continuous blood flow is achieved, but blood trauma and hemolysis occur due to absence of pulsatile flow

Engineering Contradiction:
Improveblood flow continuityVSAvoidblood trauma and hemolysis
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies periodic action by introducing a pulsatile flow mechanism that alternates between filling and emptying phases. The chamber periodically changes its internal volume to create pulse waves in the blood flow, simulating natural cardiac function. This periodic volume change is achieved through a membrane that expands and contracts in response to pressure differences, generating physiological pulsatile flow patterns that prevent blood trauma and hemolysis while maintaining continuous flow.

Inventive Principle:
Principle #19Periodic action

2Reliability

If membrane material is made elastic to allow volume variation, then pulsatile flow is generated, but stagnation points form due to distension and contraction

Engineering Contradiction:
Improvepulsatile flow generationVSAvoidstagnation points
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies parameter changes by transitioning from elastic material to impermeable flexible non-elastic material. This material parameter change allows the membrane to vary internal volume through geometric deformation rather than elastic distension. The membrane changes shape and orientation in response to pressure gradients, creating pulsatile flow without the formation of stagnation points that occur with elastic material distension and contraction.

Inventive Principle:
Principle #35Parameter changes

3Productivity

If conventional pumping methods are used, then blood is moved through the system, but blood pressure regulation is inadequate leading to cardiovascular complications

Engineering Contradiction:
Improveblood transportVSAvoidblood pressure regulation
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent applies the intermediary principle by introducing a compliant chamber with a membrane as a mediator between the blood flow system and the pumping mechanism. This intermediary chamber receives blood during diastole when pressure is lower, and releases it during systole when pressure is higher, effectively regulating blood pressure. The membrane acts as a flexible barrier that transmits pressure changes while maintaining separation, enabling physiological blood pressure regulation that prevents cardiovascular complications.

Inventive Principle:
Principle #24Intermediary (Mediator)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The membrane effectively dampens arterial pulse waves, stabilizes blood pressure, reduces hemolysis, and minimizes complications by maintaining continuous and uniform blood flow, thereby improving vascular distensibility and reducing the risk of cardiovascular events associated with hypertension.

Implementation Method 1

made from impermeable, flexible non-elastic material to prevent stagnation points and ensure continuous blood flow

Methodology Applied
Scientific EffectFlexible deformation: Deformation

Implementation Method 2

The membrane effectively dampens arterial pulse waves, stabilizes blood pressure

Methodology Applied
Scientific EffectPulse wave dampening: Damping

Implementation Method 3

provides pulsatile flow by varying internal volume without distension or contraction

Methodology Applied
Scientific EffectPulsatile flow generation:

Data Source

PatentUS12005247B2Pump for artificial circulatory assistance and a pumping system
Publication Date: 2024.06.11 ZAMMI INSTRAL
  • US12005247B2 patent drawing
  • US12005247B2 patent drawing
  • US12005247B2 patent drawing

AI summary

Membranes are provided to be specially developed for use in chambers for artificial circulatory assistance which may be employed primarily in cardiovascular procedures, notably to produce arterial capacitance, to regulate blood pressure, to produce aortic counterpulsation and to pump blood. The membrane may have circular sections that may vary in size or not depending on the function to be performed and are interconnected so that the transition between one section and the other is smooth, regardless of the size of each section. Further, chambers and pumps may be used for cardiopulmonary bypass and a pumping system.